Skip to content

Distinct pattern in bipolar depression and major depressive disorder: A multiscale imaging-transcriptomic analysis.

Sep 2026 · Psychiatry and Clinical Neurosciences · 0 citations · 66 references
Medicine

TL;DR

These findings identify distinct cortical morphometric organization in BDD and MDD, and these differences are linked to transcriptomic, cellular, and neurotransmitter-related annotations, providing multiscale insights into the neurobiological divergence between the two disorders.

Abstract

Aim

Bipolar depression (BDD) and major depressive disorder (MDD) share similar depressive symptoms but differ in diagnosis, treatment, and prognosis. Clarifying their neurobiological distinctions may improve diagnostic characterization and mechanistic understanding.

Methods

We studied 453 participants, including 85 patients with BDD, 190 with MDD, and 178 healthy controls. Individual morphometric similarity networks (MSN) were constructed using seven structural and diffusion MRI features. Regional MSN differences between BDD and MDD were examined at the parcel level. To characterize the biological relevance of the distinct MSN pattern, we performed imaging-transcriptomic analysis using Allen Human Brain Atlas data, followed by gene enrichment, cell-type enrichment, receptor/transporter dominance analysis, and cognitive meta-analytic decoding. Sensitivity analyses evaluated the effects of medication exposure and demographic imbalance.

Results

Compared with MDD, BDD showed distinct MSN alterations mainly in parietal and occipital regions, including higher MSN in the left lateral occipital cortex and lower MSN in the right inferior and superior parietal cortices. The spatial transcriptomic pattern was enriched for ribosomal and protein synthesis/modification pathways. Cell-type enrichment analyses showed that the transcriptomic pattern associated with the MSN differences was enriched for microglial and inhibitory-neuron gene signatures, while receptor dominance analysis identified the 5-HT2A density map as having the largest relative contribution to the explained spatial variance.

Conclusion

Our findings identify distinct cortical morphometric organization in BDD and MDD, and these differences are linked to transcriptomic, cellular, and neurotransmitter-related annotations, providing multiscale insights into the neurobiological divergence between the two disorders.

View source

Similar papers

Sep 2026

Cognitive heterogeneity in major depressive disorder: Neuroimaging, transcriptomic, and neurotransmitter profiles.

This study provides a data-driven characterization of cognitive heterogeneity in MDD, identifying two cognitive dimensions spanning from relative preservation to widespread impairment, and provides preliminary biological context for interpreting cognitive heterogeneity in MDD.

Yu-Shun Yan, Jia'ao Yu, Liang Zuo et al. · 0 citations
Open access Jan 2026

Connectome Gradient‐Based Subtyping of Major Depressive Disorder Reveals Distinct Neurobiological and Transcriptomic Signatures

Background/Objective Major depressive disorder (MDD) exhibits significant heterogeneity, and identifying these distinct biological subtypes aids clinical intervention. In this study, we employed functional gradient and Hydra clustering methods to distinguish subtypes of depression. Method Imaging data were derived from...

Xiao-Zheng Liu, Zhong-Wei Guo · 0 citations
Open access Aug 2026

Sex differences in symptom-specific brain abnormalities across disease stages in depression

The incidence and clinical manifestations of major depressive disorder (MDD) differ between sexes. This implies distinct neuropathological mechanisms. This study aimed to investigate sex-specific brain patterns in MDD by stratifying patients according to both sex and disease course. We recruited 1170 parti...

Xiao-Qin Wang, Yi Xia, Jun-Chen Bao et al. · 0 citations
Open access Aug 2026

Baseline cortical structural features are associated with depressive and cognitive improvement in major depressive disorder

Major depressive disorder (MDD) exhibits substantial clinical and neurobiological heterogeneity, along with marked variability in treatment response, underscoring the need for objective neuroimaging markers to inform personalized interventions. Twenty-two patients with MDD and twenty-one age- and sex-mat...

Yingna Li, Shuping Tian, Siyan Zan et al. · 0 citations
Open access Sep 2026

780. Classification of Major Depressive Disorder Subtypes via Surface-based Brain Imaging and Clinical Features

Abstract Background Major Depressive Disorder (MDD) is characterized by substantial heterogeneity in both symptomatic presentation and underlying neurobiology, posing significant challenges for accurate diagnosis and effective intervention. While prior research has attempted to delineate MDD subtypes using only neuroim...

Z. Chen, Q. Bo, C. Wang · 0 citations
Review Open access Aug 2026

Mapping the Heterogeneity of Major Depressive Disorder: A Systematic Review of Multi-Omics Integration Studies

Results indicate that multi-omics integration, in addition to explaining the molecular architecture of MDD, also characterizes patient subgroups with pathophysiological mechanisms, dimensions of symptoms, and disease treatment, which demonstrates that there is a shift in psychiatry toward a more mechanistic approach.

Elham Amjad, B. Sokouti · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.